Healthcare

FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment

Approval allows for larger field treatment of actinic keratosis (AK) on face and scalp with Ameluz®-PDT using the BF-RhodoLED or...

Intellia Therapeutics Announces Initiation of HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)

NTLA-2002 is a single-dose treatment designed to prevent potentially life-threatening swelling attacks in people with hereditary angioedema (HAE)NTLA-2002 is Intellia’s...

Orchard Therapeutics and Er-Kim Announce Partnership to Broaden Access to Libmeldy to Eligible Patients in Turkey and Certain Eurasian Countries

ISTANBUL and LONDON, and BOSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the...

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant

Bone Health and Osteoporosis Foundation (BHOF) Awarded Multi-Year Grant to Increase Bone Health Awareness from the Centers for Disease Control and Prevention (CDC)

ARLINGTON, Va., Oct. 4, 2024 /PRNewswire/ -- The Bone Health and Osteoporosis Foundation announced that it has been awarded a major...

Brain Computer Interface (BCI) Market is expected to generate a revenue of USD 10.86 Billion by 2031, Globally, at 14.61% CAGR: Verified Market Research®

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its...

Disaster Recovery Software Market Poised for Significant Growth: Expected to Reach USD 12.3 Billion by 2031, Driven by Rising Cybersecurity Threats and Increased Cloud Adoption: Market Research Intellect

error: Content is protected !!